(Q51994285)

19 April 2018

meta-analysis

0 references

title

Antidepressants in child and adolescent depression: where are the bugs? (English)

1 reference

19 April 2018

1 reference

1

1 reference

19 April 2018

Celso Arango

2

1 reference

19 April 2018

author name string

Parellada M

3

1 reference

19 April 2018

Shaffer D

4

1 reference

19 April 2018

Bird H

5

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 March 2007

1 reference

19 April 2018

Acta Psychiatrica Scandinavica

published in

1 reference

19 April 2018

volume

115

1 reference

19 April 2018

issue

3

1 reference

19 April 2018

page(s)

184-195

1 reference

19 April 2018

The clinical picture of major depression in children and adolescents

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Psychiatric disorder, impairment, and service use in rural African American and white youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Childhood and adolescent depression: a review of the past 10 years. Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Depression treatment during outpatient visits by U.S. children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Trends in the prescribing of psychotropic medications to preschoolers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Rising prevalence of antidepressants among US youths

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Fluoxetine for the treatment of childhood anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Review of the efficacy and safety of antidepressants in youth depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

The use of antidepressants to treat depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Efficacy and safety of antidepressants for children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Pharmacotherapy of child and adolescent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

ACNP Task Force report on SSRIs and suicidal behavior in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Forty years of antidepressant drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Placebo response in studies of major depression: variable, substantial, and growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Imipramine in prepubertal major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Adolescent depression: controlled desipramine treatment and atypical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Are child-, adolescent-, and adult-onset depression one and the same disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Age effects on antidepressant-induced manic conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Risk of mania with antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Children of depressed parents. Increased psychopathology and early onset of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

A controlled family history study of prepubertal major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Clinical trials in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Psychopharmacological treatment of major depressive disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Internalizing disorders in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Diagnosis and measurement of adolescent depression: a review of commonly utilized instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Unipolar depression in adolescents: clinical outcome in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Psychopathology associated with suicidal ideation and attempts among children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Risk factors for adolescent suicide. A comparison of adolescent suicide victims with suicidal inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Evidence of cost-effective treatments for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Efficacy of interpersonal psychotherapy for depressed adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Fluoxetine in child and adolescent depression: acute and maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

The DST as a predictor of outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

Omega-3 Treatment of Childhood Depression: A Controlled, Double-Blind Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00951.X

10.1111/J.1600-0447.2006.00951.X

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

17302618

1 reference

19 April 2018